Cton Corporation

Cton Corporation was paid $2.81M by Medicaid between Jan 2018 and Nov 2024, across 69 billing codes. Its largest line is G0483, Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed — 42% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in California

Rank by total paid#133 of 561

Median peer was paid$222K

This provider vs. median13×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	35,134	$853K
2019	35,492	$728K
2020	12,353	$394K
2021	10,904	$266K
2022	11,727	$234K
2023	17,735	$250K
2024incomplete	15,184	$85K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed	42%	14,503	6,526	$1.18M
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	15%	14,647	14,259	$424K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	15%	14,543	14,173	$419K
87806		7.1%	8,079	7,977	$199K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	4.1%	3,499	2,177	$115K
86592		2.7%	21,135	20,796	$77K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	2.2%	3,440	3,120	$63K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	1.9%	12,570	10,271	$53K
80055		1.3%	1,230	1,227	$35K
80053	Comprehensive metabolic panel	1.1%	6,462	5,718	$31K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	1.0%	997	756	$29K
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	<1%	444	318	$27K

57 more codes

80061	Lipid panel	<1%	3,488	$20K
84702		<1%	1,664	$20K
84443	Thyroid stimulating hormone (TSH)	<1%	2,776	$18K
83036	Hemoglobin; glycosylated (A1C)	<1%	3,762	$18K
86703		<1%	1,296	$15K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	861	$12K
86762		<1%	1,316	$12K
80048	Basic metabolic panel (calcium, ionized)	<1%	2,009	$8K
82140		<1%	810	$5K
87086	Culture, bacterial; quantitative colony count, urine	<1%	994	$3K
80165		<1%	700	$3K
P9603	Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled	<1%	3,821	$2K
81001		<1%	1,273	$2K
G0471	Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha)	<1%	4,248	$2K
84134		<1%	397	$2K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	299	$2K
87186		<1%	533	$2K
87184		<1%	989	$2K
87350		<1%	182	$1K
87070		<1%	483	$1K
84439		<1%	347	$1K
82950		<1%	427	$1K
87088		<1%	494	$1K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	28	$870.20
82607		<1%	128	$633.68
84153		<1%	77	$593.72
86901		<1%	110	$487.82
83540		<1%	169	$474.87
81000		<1%	458	$413.68
87340		<1%	351	$412.17
80164		<1%	42	$359.58
82746		<1%	46	$299.29
82951		<1%	28	$283.92
85014		<1%	134	$279.78
83550		<1%	91	$265.56
86900		<1%	225	$224.88
82977		<1%	112	$214.77
86803		<1%	186	$186.03
86850		<1%	224	$164.99
83735		<1%	37	$161.18
80076		<1%	50	$159.20
87147		<1%	44	$154.88
80050	General health panel	<1%	128	$131.67
85013		<1%	53	$107.59
82248		<1%	87	$98.73
84100		<1%	27	$87.37
82947		<1%	78	$83.16
87081		<1%	14	$71.54
36415	Collection of venous blood by venipuncture	<1%	262	$64.38
86708		<1%	176	$60.78
85018		<1%	27	$55.89
86706		<1%	174	$51.36
86140		<1%	13	$28.74
85610		<1%	21	$23.34
85652		<1%	28	$19.50
86704		<1%	170	$9.75
84550		<1%	13	$7.98

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialKABBANI, ISSAM (CEO)

Same official

Other billing entities under KABBANI, ISSAM

Full network →

Provider	Location	Paid
Vitae Diagnostics Incorporated	Torrance, CA	$5.12M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.